Previous 10 | Next 10 |
2024-03-08 21:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-08 09:47:01 ET Genius Sports Limited (GENI) GENI is trading DOWN for the last 4 days, and it at trading at $6.26 with volume of 1,145,622 and a one day change of $-0.03 (-0.54%). Genius Sports Limited has a 52-week low of 3.55 and a 52-week high of $8.45. The business's 50-d...
BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in...
PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models The PYX-201 target EDB+FN is found overexpressed across multiple human solid tumor types BOSTON, March 05, 2024 (GLOBE NEWSWIRE) -- Pyx...
BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it has agreed to sell 8,849,371 shares of its common stock a...
2024-01-29 16:59:37 ET Gainers: Sanmina Corporation ( SANM ) +15% . Woodward ( WWD ) +7% . F5 ( FFIV ) +7% . Super Micro Computer ( SMCI ) +6% . Alpine Immune Sciences ( ALPN ) +4% . Losers: J-Long Group ( J...
2024-01-26 09:45:09 ET Pyxis Oncology Inc. (PYXS) PYXS is trading UP for the last 5 days, and it at trading at $3.19 with volume of 3,663,280 and a one day change of $0.03 (0.92%). Pyxis Oncology Inc. has a 52-week low of 1.35 and a 52-week high of $6.92. The business's 50-day movin...
2024-01-23 08:24:49 ET Rail Vision ( RVSN ) +29% . TKO Group Holdings ( TKO ) +19% . vTv Therapeutics ( VTVT ) +18% . Bit Brother ( BETS ) +13% . Jeffs Brands ( JFBR ) +10% . Rumble ( RUM )...
2024-01-17 20:15:07 ET Summary Pyxis Oncology is a biotech company focused on developing immunotherapies for cancer treatment. Their most advanced pipeline project is sotigalimab, a CD40 agonist, which has shown promising results in melanoma and liposarcoma. The company has en...
2024-01-04 16:19:31 ET Gainers: Molecular Partners ( MOLN ) +14% . Sutro Biopharma ( STRO ) +9% . Ribbon Communications ( RBBN ) +7% . Resources Connection ( RGP ) +7% . Pyxis Oncology ( PYXS ) +6% . Losers: 89bio ( ETN...
News, Short Squeeze, Breakout and More Instantly...
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effecti...
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer PYX-106 Phase 1 trial clinical readout on track for 2H 2024 Expected cash runway i...